355 related articles for article (PubMed ID: 32366502)
1. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
Bergmann CC; Silverman RH
Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
[No Abstract] [Full Text] [Related]
2. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
3. [COVID-19- what have we learned and where are we heading?].
Gudnason T
Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
[No Abstract] [Full Text] [Related]
4. A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.
Zhang YZ; Holmes EC
Cell; 2020 Apr; 181(2):223-227. PubMed ID: 32220310
[TBL] [Abstract][Full Text] [Related]
5. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.
Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092
[TBL] [Abstract][Full Text] [Related]
6. Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.
Xiao F; Sun J; Xu Y; Li F; Huang X; Li H; Zhao J; Huang J; Zhao J
Emerg Infect Dis; 2020 Aug; 26(8):1920-1922. PubMed ID: 32421494
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
8. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV.
Lee PI; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):365-367. PubMed ID: 32035811
[No Abstract] [Full Text] [Related]
9. [COVID-19: Pathogenesis of a multi-faceted disease].
Bonny V; Maillard A; Mousseaux C; Plaçais L; Richier Q
Rev Med Interne; 2020 Jun; 41(6):375-389. PubMed ID: 32507520
[TBL] [Abstract][Full Text] [Related]
10. Ten things we learned about COVID-19.
Cecconi M; Forni G; Mantovani A
Intensive Care Med; 2020 Aug; 46(8):1590-1593. PubMed ID: 32504103
[No Abstract] [Full Text] [Related]
11. Modeling infectious disease dynamics.
Cobey S
Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
[No Abstract] [Full Text] [Related]
12. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
Woodruff TM; Shukla AK
Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 convalescent plasma: phase 2.
Knudson CM; Jackson JB
Transfusion; 2020 Jun; 60(6):1332-1333. PubMed ID: 32374890
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 antibodies on trial.
DeFrancesco L
Nat Biotechnol; 2020 Nov; 38(11):1242-1252. PubMed ID: 33087898
[TBL] [Abstract][Full Text] [Related]
15. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
16. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
[TBL] [Abstract][Full Text] [Related]
17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Major Hemorrhage in COVID-19 Patients: Another Brick in the Wall of SARS-CoV-2-Associated Coagulation Disorders?
Palumbo D; Guazzarotti G; De Cobelli F
J Vasc Interv Radiol; 2020 Sep; 31(9):1494-1496. PubMed ID: 32768277
[No Abstract] [Full Text] [Related]
19. COVID-19 and cancer: do we really know what we think we know?
Robinson AG; Gyawali B; Evans G
Nat Rev Clin Oncol; 2020 Jul; 17(7):386-388. PubMed ID: 32424196
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free Therapies: Novel Approaches for COVID-19.
Maron-Gutierrez T; Rocco PRM
Front Immunol; 2020; 11():583017. PubMed ID: 33072130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
